Dopamine antagonist and 'binge' cocaine effects on rat opioid and dopamine transporter mRNAs

THE modulation by selective dopamine receptor antagonists of the effects of 'binge' cocaine (3 x 15 mg kg(-1) day(-1), i.p., far 3 days after II days of adaptation to saline injections) on preproenkephalin, preprodynorphin, kappa opioid receptor and dopamine transporter mRNAs was determined, Adminstration of cocaine was preceded by daily single injections of a D1 (SCH 23390; 2 mg kg(-1)) or the D2 (sulpiride; 50 mg kg(-1)) dopamine receptor antagonist. The D1, and not the D2, antagonist blocked cocaine-induced preprodynorphin and preproenkephalin increases in the caudate-putamen. Sulpiride alone, and sulpiride plus cocaine, increased preproenkephalin mRNA. Dopamine transporter mRNA levels showed a cocaine treatment-antagonist interaction. These data indicate that this administration paradigm elevates both preprodynorphin and preproenkepharin mRNAs by a D1-dependent mechanism not requiring D2 activation.